Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.
D001702:Biopharmaceutics; D006207:Half-Life; D007408:Intestinal Absorption; D007700:Kinetics; D009582:Nitrofurantoin / Q000592:standards*; D010602:Pharmacopoeias as Topic; D012995:Solubility; D013535:Suspensions / Q000592:standards; D013607:Tablets / Q000592:standards; D014481:United States
D013535:Suspensions; D013607:Tablets; D009582:Nitrofurantoin